Real-Life Treatment Paradigms Show Adalimumab Is Cost-Effective for the Management of Ulcerative Colitis

Background. Adalimumab is effective for the maintenance of remission in patients with moderate-to-severe ulcerative colitis (UC). Currently, biologic therapies are used in cases where patients fail conventional medical therapies. If biologic therapies are not available, patients often choose to rema...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Can J Gastroenterol Hepatol
Auteurs principaux: Beilman, Candace L., Thanh, Nguyen Xuan, Ung, Victoria, Ma, Christopher, Wong, Karen, Kroeker, Karen I., Lee, Thomas, Wang, Haili, Ohinmaa, Arto, Jacobs, Phil, Halloran, Brendan P., Fedorak, Richard N.
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2016
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5065999/
https://ncbi.nlm.nih.gov/pubmed/27781203
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5315798
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires